Status:
NOT_YET_RECRUITING
Prognostic Role of Lipoprotein(a) in Elective Percutaneous Coronary Revascularization
Lead Sponsor:
Assiut University
Conditions:
PCI
Eligibility:
All Genders
18+ years
Brief Summary
The study investigates the role of Lipoprotein(a) \[Lp(a)\] levels in predicting cardiovascular risk and adverse events in patients undergoing elective percutaneous coronary intervention (PCI).
Detailed Description
his is a multicenter prospective observational cohort study conducted at Assiut University Heart Hospital and affiliated centers. The study focuses on patients undergoing elective (non-ACS) PCI for st...
Eligibility Criteria
Inclusion
- Adults aged 18 years or older
- Undergoing elective PCI for stable coronary artery disease
- Ability to provide informed consent
- Willingness to undergo blood sampling prior to PCI
Exclusion
- Acute coronary syndrome within 30 days
- Cardiogenic shock
- Prior heart transplant or left ventricular assist device (LVAD)
- Life expectancy less than 1 year due to non-cardiac causes
- Participation in a blinded Lp(a)-lowering outcome trial at the time of enrollment
Key Trial Info
Start Date :
October 1 2026
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2027
Estimated Enrollment :
156 Patients enrolled
Trial Details
Trial ID
NCT07197242
Start Date
October 1 2026
End Date
December 30 2027
Last Update
September 29 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.